One of the 12 market segments covered by the latest (2013/14) edition of LaingBuisson’s Healthcare Market Review has been immune from government austerity measures and pressures on disposable income. But with some exceptions – including those companies which still have a massive debt overhang from pre-crunch days – they remain in fundamentally good shape, with…
Membership Required
You must be a CM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
